作者：
Łukasz,Sędek [1]
;
Juan,Flores-Montero [2]
;
Alita,van der Sluijs [3]
;
Jan,Kulis [4]
;
Jeroen,Te Marvelde [5]
;
Jan,Philippé [6]
;
Sebastian,Böttcher [7]
;
Marieke,Bitter [8]
;
Joana,Caetano [9]
;
Vincent H J,van der Velden [10]
;
Edwin,Sonneveld [11]
;
Chiara,Buracchi [7]
;
Ana Helena,Santos [12]
;
Margarida,Lima [13]
;
Tomasz,Szczepański [14]
;
Jacques J M,van Dongen [14]
;
Alberto,Orfao [6]
作者单位：
Department of Microbiology and Immunology, Medical University of Silesia in Katowice (SUM), 41-808 Zabrze, Poland.
[1]
Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca (USAL), 37007 Salamanca, Spain.
[2]
Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
[3]
Center of Biomedical Network Research in Cancer (CIBER ONC), Carlos III Institute of Health, 28029 Madrid, Spain.
[4]
Department of Immunology, Leiden University Medical Center (LUMC), 2300 RC Leiden, The Netherlands.
[5]
Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice (SUM), 41-800 Zabrze, Poland.
[6]
Department of Immunology, Erasmus MC, University Medical Center Rotterdam, 3015 CN Rotterdam, The Netherlands.
[7]
Department of Diagnostic Sciences, Ghent University, 9000 Ghent, Belgium.
[8]
Special Hematology Laboratory, Medical Clinic III, Hematology, Oncology and Palliative Medicine, Rostock University Medical Center, 18057 Rostock, Germany.
[9]
European Scientific Foundation for Laboratory Hemato Oncology (ESLHO), 2333 ZA Leiden, The Netherlands.
[10]
Clinical Flow, Hemato-Oncology Unit, Champalimaud Foundation, 1400-038 Lisboa, Portugal.
[11]
Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
[12]
Pediatric Clinic of Milano-Bicocca, Tettamanti Research Center, Monza (TRC), 20900 Monza, Italy.
[13]
Department of Hematology, Central Hospital of Porto (CHP), 4099-001 Porto, Portugal.
[14]
DOI
10.3390/cancers14030473
PMID
35158741
发布时间
2022-02-19
换一批
换一批
